Multiple sclerosis in the Iranian immigrant population of BC, Canada: Prevalence and risk factors

Multiple Sclerosis Journal

Volumn 20, Issue 9, 2014, Pages 1182-1188

  Guimond, Colleen ^a   Lee, Joshua D ^a   Ramagopalan, Sreeram V ^b,c   Dyment, David A ^d   Hanwell, Heather ^e,f   Giovannoni, Gavin ^g   Criscuoli, Maria ^a   Yee, Irene M ^a   Vorobeychik, Galina ^h   Ebers, George C ^b,c   Sadovnick, A Dessa ^a,i  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h Department of Neurology Fraser Health Multiple Sclerosis Clinic   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Canada; cohort studies; environment; epidemiology; genetics; Iranian; multiple sclerosis; prevalence; risk factors

Indexed keywords

HLA DRB1 ANTIGEN; VITAMIN D; EPSTEIN BARR VIRUS ANTIGEN 1; BIOLOGICAL MARKER;

ADULT; ALLELE; ARTICLE; CANADA; COMPARATIVE STUDY; CONSANGUINITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; FEMALE; FIRST DEGREE RELATIVE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC RISK; HUMAN; IMMIGRANT; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIGRATION; MONONUCLEOSIS; MULTIPLE SCLEROSIS; ONSET AGE; RECURRENCE RISK; RISK FACTOR; SEROLOGY; SEX RATIO; SIBLING; SMOKING; SPOUSE; GENE; HLA DRB1 GENE; IRAN; IRANIAN (CITIZEN); LONGITUDINAL STUDY; PREVALENCE; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; BLOOD; BRITISH COLUMBIA; CASE CONTROL STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MIGRANT; ODDS RATIO; YOUNG ADULT;

ADULT; AGE OF ONSET; BIOMARKERS; BRITISH COLUMBIA; CASE-CONTROL STUDIES; EMIGRANTS AND IMMIGRANTS; EMIGRATION AND IMMIGRATION; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; IRAN; MALE; MULTIPLE SCLEROSIS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84904182647     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513519179     Document Type: Article

References (25)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000 ; 343: 938-952
2. Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: Risk factors, prodromes and potential causal pathways. Lancet Neurol. 2010 ; 9: 727-739
3. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9: 520-532
4. Ahlgren C, Lycke J, Oden A, et al. High risk of MS in Iranian immigrants in Gothenburg, Sweden. Mult Scler. 2010 ; 16: 1079-1082
5. Ahlgren C, Oden A, Lycke J. A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden. Mult Scler. 2012 ; 18: 1099-1107
6. Guimond C, Dyment DA, Ramagopalan SV, et al. Prevalence of MS in Iranian immigrants to British Columbia, Canada. J Neurol. 2010 ; 257: 667-668
7. Saadatnia M, Etemadifar M, Maghzi AH. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol. 2007 ; 79: 357-375
8. Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler. 2011 ; 17: 1022-1027
9. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, Phase 2: Rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci. 1998 ; 25: 216-221 (Pubitemid 28368797)
10. Ramagopalan SV, Morris AP, Dyment DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 2007 ; 3: 1607-1613 (Pubitemid 47510254)
11. Shams S, Amirzargar AA, Yousefi M, et al. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol. 2009 ; 29: 175-179
12. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009 ; 42: 1549-1556
13. Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: Population based study. Brit Med J. 2005 ; 330: 120
14. Alonso A, Cook SD, Maghzi AH, et al. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler. 2011 ; 17: 550-555
15. Smestad C, Sandvik L, Holmoy T, et al. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol. 2008 ; 255: 49-55
16. Beck CA, Metz LM, Svenson LW, et al. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 ; 11: 516-519 (Pubitemid 41387694)
17. Sahraian MA, Khorramnia S, Ebrahim MM, et al. Multiple sclerosis in Iran: A demographic study of 8000 patients and changes over time. Eur Neurol. 2010 ; 64: 331-336
18. Maghzi AH, Ghazavi H, Ahsan M, et al. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: A population-based study. Mult Scler. 2010 ; 16: 359-361
19. Kurtzke JF. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurol Scand. 1980 ; 62: 65-80 (Pubitemid 10048468)
20. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol. 2006 ; 5: 932-936 (Pubitemid 44556546)
21. Ghabaee M, Bayati A, Amri Saroukolaei S, et al. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol. 2009 ; 29: 109-114
22. Shahbazi M, Roshandel D, Ebadi H, et al. High frequency of the IL-2-330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clin Immunol. 2010 ; 137: 134-138
23. Shahbazi M, Roshandel D, Omidnyia E, et al. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Clin Immunol. 2011 ; 139: 277-281
24. Kollaee A, Ghaffarpor M, Ghlichnia HA, et al. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis. Int J Immunogenet. 2012 ; 39: 414-422
25. Farjadian S, Ota M, Inoko H, et al. The genetic relationship among Iranian ethnic groups: An anthropological view based on HLA class II gene polymorphism. Mol Biol Rep. 2009 ; 36: 1943-1950